582
Participants
Start Date
May 31, 2010
Primary Completion Date
July 31, 2011
Agomelatine (AGO178C)
Agomelatine (AGO178C)
Placebo
Montefiore Medical Center, The Bronx
Neurobehavioral Research Inc., Cedarhurst
Neurological Associates Of Albany, P.C., Albany
Finger Lakes Clinical Research, Rochester
Lehigh Center for Clinical Research, Allentown
Alliance Research Group, LLC, Richmond
Birmingham Psychiatry, Birmingham
Northwest Behavioral Research Center, Marietta
Atlanta Center for Medical Research, Atlanta
Florida Clinical Research Center LLC, Maitland
CNS Healthcare, Orlando
Clinical Research Institute of South Florida, Hialeah
Broward Research Group, Pembroke Pines
Quantum Lab. N. Broward Memory Disorder Center, Pompano Beach
Psychiatric Consultants, Franklin
The Ohio State University - Harding Hospital, Columbus
Midwest Clinical Research Center, Dayton
Odyssey Research Services, Fargo
Rush University Medical Center, Chicago
Comprehensive Psychiatric Associates, Gladstone
CTT Clinical Trials Technology, Prairie Village
Psychiatric Associates, Overland Park
Clinical Trials Management, Metairie
IPS Research Company, Oklahoma City
Cutting Edge Research, Oklahoma City
InSite Clinical Research, DeSoto
KRK Medical Research, Dallas
FutureSearch Trials of Dallas, Dallas
Texas Center for Drug Development, Houston
University of Colorado Denver, Aurora
Western Affiliated Research Institute, Denver
Mountain West Clinical Trials, Eagle
Albuquerque Neuroscience, Albuquerque
Southwestern Research Institute, Beverly Hills
Cnri-La, Llc, Pico Rivera
Pharmacology Research Institute, Encino
Excell Research, Inc, Oceanside
CNRI San Diego, San Diego
University of California San Diego Medical Center, San Diego
Mood & Anxiety Research, Fresno
Hawaii Clinical Research Center, Honolulu
Sunstone Medical Research, LLC, Medford
Northwest Clinical Research Center, Bellevue
Mount Auburn Medical Associates, Watertown
Coastal Research Associates, Weymouth
Psychopharmacology Research Association of Princeton, Princeton
Bio Behavioral Health, Toms River
Inspira Clinical Research, San Juan
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY